113 related articles for article (PubMed ID: 12065933)
1. Fibrous dysplasia.
Schoenau E; Rauch F
Horm Res; 2002; 57 Suppl 2():79-82. PubMed ID: 12065933
[TBL] [Abstract][Full Text] [Related]
2. Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatment.
Chapurlat RD; Hugueny P; Delmas PD; Meunier PJ
Bone; 2004 Jul; 35(1):235-42. PubMed ID: 15207763
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone.
Chapurlat RD; Delmas PD; Liens D; Meunier PJ
J Bone Miner Res; 1997 Oct; 12(10):1746-52. PubMed ID: 9333137
[TBL] [Abstract][Full Text] [Related]
4. Fibrous dysplasia of bone.
Chapurlat RD; Meunier PJ
Baillieres Best Pract Res Clin Rheumatol; 2000 Jun; 14(2):385-98. PubMed ID: 10925751
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoids decrease interleukin-6 levels and induce mineralization of cultured osteogenic cells from children with fibrous dysplasia.
Stanton RP; Hobson GM; Montgomery BE; Moses PA; Smith-Kirwin SM; Funanage VL
J Bone Miner Res; 1999 Jul; 14(7):1104-14. PubMed ID: 10404010
[TBL] [Abstract][Full Text] [Related]
6. Osteoblast-specific expression of the fibrous dysplasia (FD)-causing mutation Gsα(R201C) produces a high bone mass phenotype but does not reproduce FD in the mouse.
Remoli C; Michienzi S; Sacchetti B; Consiglio AD; Cersosimo S; Spica E; Robey PG; Holmbeck K; Cumano A; Boyde A; Davis G; Saggio I; Riminucci M; Bianco P
J Bone Miner Res; 2015 Jun; 30(6):1030-43. PubMed ID: 25487351
[TBL] [Abstract][Full Text] [Related]
7. Cellular and molecular basis of fibrous dysplasia.
Marie PJ
Histol Histopathol; 2001 Jul; 16(3):981-8. PubMed ID: 11510989
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates for the treatment of fibrous dysplasia of bone.
Chapurlat R; Legrand MA
Bone; 2021 Feb; 143():115784. PubMed ID: 33276154
[TBL] [Abstract][Full Text] [Related]
9. Expression of an active Gα
Zhao X; Deng P; Iglesias-Bartolome R; Amornphimoltham P; Steffen DJ; Jin Y; Molinolo AA; de Castro LF; Ovejero D; Yuan Q; Chen Q; Han X; Bai D; Taylor SS; Yang Y; Collins MT; Gutkind JS
Proc Natl Acad Sci U S A; 2018 Jan; 115(3):E428-E437. PubMed ID: 29282319
[TBL] [Abstract][Full Text] [Related]
10. [Fibrous dysplasia of bone].
Orcel P; Chapurlat R
Rev Prat; 2007 Oct; 57(16):1749-55. PubMed ID: 18092715
[TBL] [Abstract][Full Text] [Related]
11. Medical therapy in adults with fibrous dysplasia of bone.
Chapurlat RD
J Bone Miner Res; 2006 Dec; 21 Suppl 2():P114-9. PubMed ID: 17228999
[TBL] [Abstract][Full Text] [Related]
12. Changes in gene expression in human skeletal stem cells transduced with constitutively active Gsα correlates with hallmark histopathological changes seen in fibrous dysplastic bone.
Raimondo D; Remoli C; Astrologo L; Burla R; La Torre M; Vernì F; Tagliafico E; Corsi A; Del Giudice S; Persichetti A; Giannicola G; Robey PG; Riminucci M; Saggio I
PLoS One; 2020; 15(1):e0227279. PubMed ID: 31999703
[TBL] [Abstract][Full Text] [Related]
13. [Progresses in the study of fibrous dysplasia of the jaw bone].
Chen F; Guo CB
Shanghai Kou Qiang Yi Xue; 2009 Oct; 18(5):540-4. PubMed ID: 19907865
[TBL] [Abstract][Full Text] [Related]
14. The CREB-Smad6-Runx2 axis contributes to the impaired osteogenesis potential of bone marrow stromal cells in fibrous dysplasia of bone.
Fan QM; Yue B; Bian ZY; Xu WT; Tu B; Dai KR; Li G; Tang TT
J Pathol; 2012 Sep; 228(1):45-55. PubMed ID: 22450860
[TBL] [Abstract][Full Text] [Related]
15. Pamidronate treatment in bone fibrous dysplasia in children and adolescents with McCune-Albright syndrome.
Matarazzo P; Lala R; Masi G; Andreo M; Altare F; de Sanctis C
J Pediatr Endocrinol Metab; 2002; 15 Suppl 3():929-37. PubMed ID: 12199352
[TBL] [Abstract][Full Text] [Related]
16. Fibrous dysplasia of bone and McCune-Albright syndrome.
Chapurlat RD; Orcel P
Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):55-69. PubMed ID: 18328981
[TBL] [Abstract][Full Text] [Related]
17. Direct evidence for the age-dependent demise of GNAS-mutated cells in oral fibrous dysplasia.
Isobe Y; Takahashi K; Kiso H; Nakao K; Ikeno M; Koyama N; Sugai M; Shimizu A; Haga H; Bessho K
Arch Oral Biol; 2018 Sep; 93():133-140. PubMed ID: 29909118
[TBL] [Abstract][Full Text] [Related]
18. Constitutive expression of Gsα(R201C) in mice produces a heritable, direct replica of human fibrous dysplasia bone pathology and demonstrates its natural history.
Saggio I; Remoli C; Spica E; Cersosimo S; Sacchetti B; Robey PG; Holmbeck K; Cumano A; Boyde A; Bianco P; Riminucci M
J Bone Miner Res; 2014 Nov; 29(11):2357-68. PubMed ID: 24764158
[TBL] [Abstract][Full Text] [Related]
19. Age-Related Changes and Effects of Bisphosphonates on Bone Turnover and Disease Progression in Fibrous Dysplasia of Bone.
Florenzano P; Pan KS; Brown SM; Paul SM; Kushner H; Guthrie LC; de Castro LF; Collins MT; Boyce AM
J Bone Miner Res; 2019 Apr; 34(4):653-660. PubMed ID: 30645769
[TBL] [Abstract][Full Text] [Related]
20. [Fibrous dysplasia: overview].
Akasbi N; Abourazzak FE; Talbi S; Tahiri L; Harzy T
Pan Afr Med J; 2015; 21():21. PubMed ID: 26401215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
